Economics and Management in the Biopharmaceutical Industry in the USA: Evolution and Strategic Change

Discover the dynamic interplay of policy, finance, and science shaping U.S. biopharmaceutical firms as Rachel Kim examines market trends, regulatory hurdles, and innovation strategies that drive industry transformation.

Share: